U.S. senate votes to maintain big pharma's monopoly by blocking competitive imports
May 22, 2010
NaturalNews.com
By David Gutierrez
The United States Senate recently rejected two separate proposals that would have allowed the importation of cheaper medication from other countries, apparently in order to preserve a deal between the pharmaceutical industry and the White House.
The proposals were part of a wider effort to reform the U.S. healthcare system, in large part by cutting unnecessary costs. Read more
